Table 3

 Outcome measurements by time and treatment group*

Characteristics3 months6 months12 months
“Classic” (n = 14)“Light” (n = 15)“Classic” (n = 14)“Light” (n = 15)“Classic” (n = 14)“Light” (n = 15)
*Data are given as number (%) of patients except where noted.
†Calculated with the Fisher’s exact test.
‡Calculated with the t test.
§Calculated with the U-Mann Whitney test.
Change in FTH on OCT Light (n = 14)Light (n = 14)Light (n = 14)
Decreased5 (36)4 (29)7 (50)6 (43)7 (50)6 (43)
Unchanged7 (50)8 (57)5 (43)3 (21)4 (29)3 (21)
Increased2 (14)2 (14)2 (14)5 (36)3 (21)5 (36)
p Value†10.500.79
Mean (SD) change in FTH(μm) (post-treatment value minus pretreatment value)−48.21 (88)−15.86 (46)−63.78 (105)−14.86 (85)−47.86 (121)6.36 (135)
p Value‡0.2320.1890.274
Change in CSMO on biomicroscopy
Reduced/eliminated8 (57)4 (26)7 (50)5 (33)10 (71)5 (33)
Increased0 (0)1 (7)0 (0)2 (13)2 (14)2 (13)
p Value†0.190.540.09
Reduction/resolution of leakage on FA 8 (57)9 (56)11 (79)10 (63)10 (71)9 (56)
p Value†0.96#0.680.70
Change in visual acuity
⩾5 letters increase4 (29)3 (20)2 (14)7 (47)5 (36)5 (33)
No change8 (57)12 (80)12 (86)6 (40)7 (50)8 (53)
⩾5 letters decrease2 (14)0 (0)0 (0)2 (12)2 (14)2 (13)
p Value†0.290.031
Mean (SD) change in No of letters (post-treatment value minus pre-treatment value)2.00 (5.22)0.80 (3.36)1.93 (4.56)2.27 (5.75)3.07 (6.50)0.80 (6.82)
p Value‡0.460.860.37
Mean (SD) change in mean deviation of central 10° sensitivity (post-treatment value minus pretreatment value)−0.81 (1.61)−0.66 (1.39)−0.04 (1.39)−0.03 (1.84)
p Value‡0.820.99
Mean No (SD) of scotomata 7.92 (6.76)7.28 (6.63)5.00 (4.96)4.78 (5.87)
p Value§0.630.40
Change (SD) in contrast sensitivity (No of letters)−0.36 (2.50)−0.07 (1.62)−0.71 (2.84)−0.40 (2.67)−1.21 (3.51)−0.27 (2.76)
p Value§0.750.850.56
No of eyes retreated001 (7)3 (20)4 (29)3 (20)
p Value†0.600.68